Ignite Creation Date:
2024-05-06 @ 1:38 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04084613
Status:
UNKNOWN
Last Update Posted:
2019-09-12
First Post:
2019-09-08
Brief Title:
Mepolizumab Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece
Sponsor:
Attikon Hospital
Organization:
Attikon Hospital
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2019-09
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A prospective multi-centre non-interventional observational study that will be conducted in several centers in Greece for a 2-year time period completion date December 2020 to describe patient characteristics medical history and the clinical benefit of mepolizumab in patients with severe eosinophilic asthma newly initiated to the drug
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None